Regulations.gov document
Memorandum re Separation of Functions; Withdrawal of Approval of New Animal Drug…
Other · FDA-2023-N-4742 · posted May 22, 2025
Key facts
| Document ID | FDA-2023-N-4742-0044 |
|---|---|
| Title | Memorandum re Separation of Functions; Withdrawal of Approval of New Animal Drug Applications for Carbadox |
| Document type | Other |
| Subtype | Memorandum |
| Agency | FDA |
| Docket | FDA-2023-N-4742 |
| Posted | May 22, 2025 |
| Comment period opens | May 22, 2025 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: